VHL vitasora health limited

http://www.bloomberg.com/news/2010-07-13/transgene-in-talks-to-li...

  1. 520 Posts.
    http://www.bloomberg.com/news/2010-07-13/transgene-in-talks-to-license-experimental-antibody-showing-cancer-promise.html

    ?We don?t want to do what the others do,? Archinard said during the interview. ?Companies that don?t have a strategic shareholder are forced to sell their assets very soon, too soon.?

    Transgene may buy technology, patents and products to expand its therapeutic vaccine and oncolytic virus businesses, Archinard said. Oncolytic viruses, Transgene?s third area of development, are engineered to infect and destroy cancer cells.

    ?A certain number of talks are under way? for possible acquisitions, Archinard said, without elaborating further.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $44.68M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $156 6.012K

Buyers (Bids)

No. Vol. Price($)
2 167796 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 146386 2
View Market Depth
Last trade - 15.03pm 12/08/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.